Previous Close | 0.0305 |
Open | 0.0305 |
Bid | 0.0000 x 2000000 |
Ask | 0.0000 x 2000000 |
Day's Range | 0.0305 - 0.0305 |
52 Week Range | 0.0100 - 0.0894 |
Volume | 2,000 |
Avg. Volume | 354 |
Market Cap | 8.735M |
Beta (5Y Monthly) | 1.54 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0290 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
VANCOUVER, BC / ACCESSWIRE / April 6, 2021 / Naturally Splendid Enterprises Ltd. ("Naturally Splendid", "NSE" or "the Company") (FRANKFURT:50N)(TSXV:NSP)(OTC PINK:NSPDF) is pleased to announce the addition of Marketing Executive, Drago Adam to their Advisory Board.
VANCOUVER, BC / ACCESSWIRE / April 1, 2021 / Naturally Splendid Enterprises Ltd.("Naturally Splendid", "NSE" or "the Company") (FRANKFURT:50N) (TSX-V:NSP) (OTC:NSPDF) provides an update on the Health Canada approved, COVID-19 phase 2 clinical trial and strategic outlook for Plasm Pharmaceutical and development of the target drug CavaltinibTM.
VANCOUVER, BC / ACCESSWIRE / March 30, 2021 / Naturally Splendid Enterprises Ltd. ("Naturally Splendid") (TSX-V:NSP) (OTC:NSPDF) (Frankfurt:50N) is pleased to announce the Company has received a Purchase Order for another container of hulled hemp seed from its roster of clients in South Korea.